Pomerantz LD, Rabe KG, Hampel PJ, Roeker LE, et al. Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general population. Leuk Lymphoma 2026 Jun 25:1-5. doi: 10.1080/10428194.2026.2687633.
PMID: 42348303